ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Imbruvica 560 mg, Filmtabletten - 28
67109008 Janssen-Cilag AG
Imbruvica 560 mg, Filmtabletten18.04.2019
  18.04.2019
Ibrutinib (L01EL01) 
WHO-DDD 
07.16.10.28
07.16.10. 
A  
Yes 
IP 
5643.42Yes
    
10 %6036.40
7680671090086Synthetika
  
Composition
ibrutinibum 560 mg, lactosum monohydricum 112 mg, carmellosum natricum conexum, natrii laurilsulfas, povidonum K 25, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 172, pro compresso obducto corresp. natrium 4.56 mg.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Ibrutinibum560 mg
BAG: Active AgentDose
Ibrutinibum560 mg
 
Inactive agentsDoseadditional_information
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Lactose Monohydrate112 mg 
Macrogol  
Magnesii Stearas  
Natrii Laurilsulfas  
Poly(Alcohol Vinylicus) Überzug
Povidonum K25  
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 08.11.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home